AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Contrast Agents Market By Product Type, By Modality Type & By Region - Global Forecast up to 2025 - ResearchAndMarkets.com

October 11, 2019

DUBLIN--(BUSINESS WIRE)--Oct 11, 2019--

The “Contrast Agents Market By Product Type (Iodinated, Barium-based, Gadolinium-based, Microbubble-based, and Others), By Modality Type (X-Ray/Computed Tomography, Magnetic Resonance Imaging, and Ultrasound), By Region - Global Forecast up to 2025” report has been added to ResearchAndMarkets.com’s offering.

Overview of the Global Contrast Agents Market

The author’s market research report predicts that the Global Contrast Agents Market will grow at a CAGR of ~4.0% during the forecast period 2019-2025.

The market has witnessed steady growth in the past few years and is sustaining due to rising demand for diagnostic and interventional radiology procedures and increase in incidence and prevalence of disease conditions are drivers of the market.

Expansion in indications of contrast media market and the growth of medical imaging technologies in emerging markets are providing opportunities for the growth of the contrast agents market. However, side effects associated with contrast agents and stringent regulations for contrast agents are factors hampering the market growth.

According to the analysis, North America accounted for the largest share of the global contrast agents market in 2018. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.

Key Competitive Facts

Benefits

The report provides complete details about the sub-segments of the contrast agents market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the disease management in the upcoming years along with details of the existing pure-play companies and new players entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Key Takeaways:

Key Topics Covered:

1 Industry Outlook

1.1 Industry Overview

1.2 Total Addressable Market

2 Report Outline

2.1 Report Scope

2.2 Report Summary

2.3 Research Methodology

2.4 Report Assumptions

3 Market Snapshot

3.1 Market Definition

3.2 Segmented Addressable Market (SAM)

3.3 Industry Trends

3.4 Related Markets

3.4.1 Medical Imaging

4 Market Outlook

4.1 Market Segmentation

4.2 Porter 5 (Five) Forces

5 Market Characteristics

5.1 Market Dynamics

5.1.1 Drivers

5.1.1.1 Rising demand for diagnostic and interventional radiology procedures

5.1.1.2 Increase in incidence and prevalence of disease conditions

5.1.2 Restraints

5.1.2.1 Side effect associated with contrast agents

5.1.2.2 Stringent regulations for contrast agents

5.1.3 Opportunities

5.1.3.1 Expansion in indications of contrast media market

5.1.3.2 The growth of medical imaging technologies in emerging markets

5.1.4 DRO - Impact Analysis

5.2 Key Stakeholders

6 Products: Market Size and Analysis

6.1 Iodine Based Contrast Agent

6.2 Barium Based Contrast Agent

6.3 Gadolinium Based Contrast Agent

6.4 Microbubble Based Contrast Agent

6.5 Other Contrast Agent

7 Modality: Market Size and Analysis

7.1 Overview

7.2 X-Ray and Computerized Tomography (CT)

7.3 Magnetic Resonance Imaging (MRI)

7.4 Ultrasound

8 Regions: Market Size and Analysis

8.1 Overview

8.2 North America

8.2.1 Overview

8.3 Europe

8.3.1 Overview

8.4 Asia Pacific

8.4.1 Overview

8.5 Rest of the World

8.5.1 Overview

9 Competitive Landscape

10 Vendors Profile

10.1 Taejoon Pharm Co., Ltd

10.2 GE Healthcare

10.3 Bayer AG

10.4 Fujifilm Holdings Corporation

10.5 Bracco Group

10.6 Guerbet

11 Companies to Watch for

11.1 Dongkook Life Science

11.2 Beijing Beilu Pharmaceutical Co., Ltd

11.3 Lantheus Medical Imaging Inc.

11.4 Sanochemia Pharmaceutical AG

11.5 JB Chemicals and Pharmaceuticals Ltd

11.6 IMAX Diagnostic Imaging Limited

For more information about this report visit https://www.researchandmarkets.com/r/xroax9

View source version on businesswire.com:https://www.businesswire.com/news/home/20191011005190/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENERAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 10/11/2019 05:53 AM/DISC: 10/11/2019 05:53 AM

http://www.businesswire.com/news/home/20191011005190/en